Phase II of Lenalidomide After Salvage Therapy in R/R Non-Hodgkin T-cell Lymphoma

NCT03730740 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

79

Enrollment

OTHER

Sponsor class

Conditions

Relapsed and/or Refractory Non-Hodgkin T-cell Lymphoma

Interventions

DRUG: Lenalidomide 25mg

Sponsor

Samsung Medical Center